According to a new report by Polaris Market Research, the global home infusion therapy market was valued at USD 38.63 billion in 2024 and is projected to reach USD 83.31 billion by 2034, expanding at a CAGR of 8.0% over the forecast period. Growth is underpinned by rising chronic disease prevalence, an aging population requiring long-term therapy, and expanding insurance support for home-based care models.

What Is Driving Home Infusion Therapy Market Growth?

Demand is climbing as the rising incidence of cancer, diabetes, and autoimmune conditions converges with growing preference for decentralized, home-based healthcare delivery. Providers and payers are prioritizing home infusion services, pushing adoption across anti-infective, chemotherapy, and nutrition therapy categories. Polaris analysts note that the World Health Organization's projection of over 35 million new global cancer cases by 2050 — a 77% increase from 2022 — positions the segment for sustained growth through 2034, with the service category emerging as the largest revenue contributor and chemotherapy posting the fastest incremental gains.

Key Trends Shaping the Home Infusion Therapy Industry

Rising Prevalence of Chronic Disease Expands the Patient Pool

Growing numbers of patients with cancer, diabetes, and autoimmune conditions require regular intravenous therapy over extended periods, reinforcing home infusion as a practical, lower-cost alternative to repeated hospital visits and strengthening long-term treatment adherence.

Aging Population Reshapes Care-Delivery Models

The World Health Organization projects that by 2050, approximately 80% of the global population aged 65 and above will reside in low- and middle-income countries, a demographic shift that is accelerating investment in geriatric-friendly home infusion models and reducing exposure to hospital-acquired infections.

Portable Infusion Technology Improves the Competitive Landscape

Improved portability, automation, and stable biologic formulations are making it easier to deliver complex therapies at home. This technology advancement is reshaping the competitive landscape as providers expand 24/7 clinical support and remote patient monitoring capabilities.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/home-infusion-therapy-market

Market Segmentation: Breaking Down the Home Infusion Therapy Market

Polaris segments the home infusion therapy market by type, application, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Type

The service segment accounted for approximately 72% of revenue in 2024, reflecting the growing need for skilled nursing, pharmacy support, and on-site administration expertise. The product segment continues to expand on rising adoption of advanced infusion pumps, IV catheters, and portable administration sets designed for independent home use.

By Application

The anti-infective segment accounted for the largest revenue share in 2024, driven by widespread use of intravenous antibiotics for outpatient treatment of infections such as osteomyelitis and cellulitis. The chemotherapy segment is projected to witness the highest CAGR during the forecast period as oncology care models shift toward home-based delivery for maintenance and palliative regimens.

Regional Outlook: Where Is the Home Infusion Therapy Market Growing Fastest?

North America accounted for approximately 57% of global revenue in 2024, supported by strong healthcare infrastructure, widespread insurance coverage, and an aging population requiring long-term care — reinforced by the Centers for Medicare & Medicaid Services' report of a 19% increase in Medicare Part B home infusion utilization in 2023. Asia Pacific is expected to grow significantly from 2025 to 2034 on rising healthcare awareness and urbanization, with China accounting for the region's dominant share as healthcare-system modernization expands post-acute care access. Europe's home infusion landscape continues to grow as payers in Germany and the UK expand favorable reimbursement policies for home-based parenteral nutrition and antibiotic therapy.

Competitive Landscape: Leading Home Infusion Therapy Companies

Key players profiled in the report include Option Care Health, Inc., Baxter, B. Braun SE, Fresenius Kabi AG, and ICU Medical, Inc., who are focusing on vertical integration, telehealth partnerships, and expanded clinical support networks to strengthen market position across the service and anti-infective segments outlined above. Recent moves include McKesson's April 2025 launch of "Specialty and Infusion for Health Systems," a customized suite supporting hospitals in building and optimizing infusion services, and Dynamic Access, LLC's February 2024 launch of Dynamic Infusion, offering home infusion nursing services for chronic autoimmune conditions.

Why It Matters for Buyers Evaluating the Home Infusion Therapy Market

For stakeholders researching the home infusion therapy market, this report benchmarks market share, segment-level pricing, and forecast data — by type, application, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing infusion-service providers, investors sizing entry points, and strategy teams tracking chemotherapy as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Industrial Vending Machine Market

Medical Equipment Maintenance Market

Scarifiers Market

How Biosensors Are Transforming Healthcare?

Chronic Care Management Software Market

Chronic Care Management Software Market

Legal AI Market

Electric Power Distribution Automation Systems Market

Pour Point Depressant Market